endpoints.news is our new home on June 1. endpts.com will still work, but the front door is now https://endpoints.news
September 19, 2018 10:21 AM EDT
News Briefing

UK ad­vis­es against cov­er­ing No­var­tis' Kym­ri­ah for adults; Ex-Mast chief Bri­an Cul­ley ap­point­ed CEO at Bi­o­Time

ENDPOINTS

→ Right on the heels of en­dors­ing the use of No­var­tis’ CAR-T Kym­ri­ah in chil­dren, the UK drug price watch­dog NICE is turn­ing its thumbs …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Sum­mit’s dis­ap­point­ing sur­vival read­out rais­es stakes for full da­ta

Sum­mit says bis­pe­cif­ic miss­es over­all sur­vival in close­ly-watched lung can­cer study

An­oth­er Bris­tol My­ers ex­ec goes to Aca­dia; David South­well takes CEO job at ARCH-backed can­cer biotech

Sanofi, Re­gen­eron re­port un­der­whelm­ing COPD da­ta for IL-33 an­ti­body, shares drop

As a chal­leng­ing first half nears a close, bio­phar­ma un­cer­tain­ty per­sists

sponsored

From weeks to days: how Aizon In­tel­li­gent Agents trans­form phar­ma val­i­da­tion

A service from the Financial Times